Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Mezzanine Equity and Stockholders' Equity

v3.23.1
Condensed Consolidated Statement of Changes in Mezzanine Equity and Stockholders' Equity - USD ($)
$ in Thousands
Total
CxApp
Common Stock
Common Stock
CxApp
Common Stock
Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
CxApp
Additional Paid-In Capital
Public Offering
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Series 7 Preferred Stock
Series 7 Preferred Stock
Additional Paid-In Capital
Series 8 Preferred Stock
Series 8 Preferred Stock
Additional Paid-In Capital
Series 4 Convertible Preferred Stock
Series 4 Convertible Preferred Stock
Convertible Preferred Stock
Series 5 Convertible Preferred Stock
Series 5 Convertible Preferred Stock
Convertible Preferred Stock
Increase (Decrease) in Temporary Equity [Roll Forward]                                        
Convertible preferred stock, beginning balance (in shares)                         49,250   0          
Convertible preferred stock, beginning balance                         $ 44,695   $ 0          
Preferred stock issued for cash (in shares)                         (49,250)   (53,198)          
Preferred stock issued for cash                         $ (49,250)   $ (41,577)          
Accretion discount - preferred shares                         $ 4,555   548          
Deemed dividend for the modification related to Series 8 Preferred Stock                             2,627          
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock                             (1,469)          
Amortization Premium- modification related to Series 8 Preferred Stock                             $ (110)          
Convertible preferred stock, ending balance (in shares) at Mar. 31, 2022                         0   53,198          
Convertible preferred stock, ending balance at Mar. 31, 2022                         $ 0   $ 43,173          
Balance, beginning (in shares) at Dec. 31, 2021                                   1   126
Balance, beginning at Dec. 31, 2021 $ 83,491   $ 2     $ 332,761     $ (695) $ 44 $ (250,309) $ 1,688           $ 0   $ 0
Balance, beginning (in shares) at Dec. 31, 2021     1,730,140                                  
Balance, beginning (in shares) at Dec. 31, 2021                 (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Shares issued for cash / offering (in shares)     57,472                                  
Shares issued for cash / offering 1,500         1,500                 5,329 $ 5,329        
Stock options and restricted stock awards granted to employees for services 1,533         1,533                            
Accretion discount - preferred shares                         $ (4,555) $ (4,555) $ (548) $ (548)        
Deemed dividend for the modification related to Series 8 Preferred Stock (2,627)         (2,627)                            
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock 1,469         1,469                            
Amortization Premium- modification related to Series 8 Preferred Stock 110         110                            
Restricted stock grants withheld for taxes (in shares)     (12,802)                                  
Restricted stock grants withheld for taxes (336)         (336)                            
Common shares issued for CXApp earnout (in shares)       144,986                                
Common shares issued for CXApp earnout   $ 3,697         $ 3,697                          
Common shares issued for exchange of warrants (in shares)     184,153                                  
Cumulative translation adjustment (102)                 (102) (15) 15                
Net loss (11,557)                   (11,211) (346)                
Balance, ending (in shares) at Mar. 31, 2022                                   1   126
Balance, ending (in shares) at Mar. 31, 2022     2,103,949                                  
Balance, ending at Mar. 31, 2022 77,404   $ 2     338,333     $ (695) (58) (261,535) 1,357           $ 0   $ 0
Balance, ending (in shares) at Mar. 31, 2022                 (1)                      
Balance, beginning (in shares) at Dec. 31, 2021                                   1   126
Balance, beginning at Dec. 31, 2021 $ 83,491   $ 2     332,761     $ (695) 44 (250,309) 1,688           $ 0   $ 0
Balance, beginning (in shares) at Dec. 31, 2021     1,730,140                                  
Balance, beginning (in shares) at Dec. 31, 2021                 (1)                      
Balance, ending (in shares) at Dec. 31, 2022                                 1 1 126 126
Balance, ending (in shares) at Dec. 31, 2022 3,570,893   3,570,894                                  
Balance, ending at Dec. 31, 2022 $ 32,115   $ 4     346,668     $ (695) 1,061 (313,739) (1,184)           $ 0   $ 0
Balance, ending (in shares) at Dec. 31, 2022 (1)               (1)                      
Increase (Decrease) in Temporary Equity [Roll Forward]                                        
Convertible preferred stock, beginning balance (in shares)                         0   53,198          
Convertible preferred stock, beginning balance                         $ 0   $ 43,173          
Convertible preferred stock, ending balance (in shares) at Mar. 31, 2023                         0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Common shares issued for extinguishment of debt (in shares) 1,547,234   1,547,234                                  
Common shares issued for extinguishment of debt $ 1,426   $ 1     1,425                            
Shares issued for cash / offering (in shares)         9,655,207                              
Shares issued for cash / offering 14,966       $ 10     $ 14,956                        
Stock options and restricted stock awards granted to employees for services 329         329                            
Deconsolidation of CXApp business as result of spin off   $ (24,230)         $ (24,230)                          
Common shares issued for net proceeds from warrants exercised (in shares)     1,380,000                                  
Common shares issued for net proceeds from warrants exercised 1   $ 1                                  
Common shares issued for exchange of warrants (in shares)     324,918                                  
Cumulative translation adjustment (1,250)                 (1,259) 26 (17)                
Net loss $ (17,178)                   (16,873) (305)                
Balance, ending (in shares) at Mar. 31, 2023                             0   1 1 126 126
Balance, ending (in shares) at Mar. 31, 2023 16,478,252   16,478,253                                  
Balance, ending at Mar. 31, 2023 $ 6,179   $ 16     $ 339,148     $ (695) $ (198) $ (330,586) $ (1,506)           $ 0   $ 0
Balance, ending (in shares) at Mar. 31, 2023 (1)               (1)                      
Increase (Decrease) in Temporary Equity [Roll Forward]                                        
Convertible preferred stock, beginning balance (in shares)                         0